Compile Data Set for Download or QSAR
Report error Found 469 of kd data for polymerid = 5059,49000249,49000251,49000255,50000525,50002456,50002638
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25746(cid_2685 | 2-hydroxy-5-{2-[(2-hydroxy-3-{4-[1-meth...)
Affinity DataKd:  776nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25748(ICI 89,406 | 3-(2-{[3-(2-cyanophenoxy)-2-hydroxypr...)
Affinity DataKd:  85nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25749(Practolol,(-) | Practolol,(+) | N-{4-[2-hydroxy-3-...)
Affinity DataKd:  1.02E+4nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25750(N-(2-{[(2R)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]a...)
Affinity DataKd:  851nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25751(Bisoprolol fumarate | Concor | [2-hydroxy-3-(4-{[2...)
Affinity DataKd:  200nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25752([(2S)-3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2...)
Affinity DataKd:  42nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25753(Artrenolol | 2-{4-[2-hydroxy-3-(propan-2-ylamino)p...)
Affinity DataKd:  1.02E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25754(2-[4-(2-{[(2R)-2-hydroxy-3-phenoxypropyl]amino}eth...)
Affinity DataKd:  1.38E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25755(N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propo...)
Affinity DataKd:  832nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25756(Betalok | Spesikor | {2-hydroxy-3-[4-(2-methoxyeth...)
Affinity DataKd:  129nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25747(4-[3-(tert-butylamino)-2-hydroxypropoxy]-2,3-dihyd...)
Affinity DataKd:  0.410nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25758(2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amin...)
Affinity DataKd:  9.30nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25759([3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-met...)
Affinity DataKd:  0.400nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25760(1-(naphthalen-2-yl)-2-(propan-2-ylamino)ethan-1-ol...)
Affinity DataKd:  44nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25761(Propanolol,(+/-) | PROPRANOLOL, l- | PROPRANOLOL,(...)
Affinity DataKd:  0.830nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25762(Sotalol,(-) | CHEMBL471 | cid_66245 | Sotalol,(+) ...)
Affinity DataKd:  141nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25763(5-[(2R)-2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl...)
Affinity DataKd:  7.94E+4nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25764(ALPRENOLOL,(-) | CHEMBL266195 | ALPRENOLOL,(+) | A...)
Affinity DataKd:  0.910nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25765(tert-butyl[3-(2-chloro-5-methylphenoxy)-2-hydroxyp...)
Affinity DataKd:  0.140nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25766(Corgard | (2R,3S)-5-[3-(tert-butylamino)-2-hydroxy...)
Affinity DataKd:  2.5nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25767(tert-butyl(2-hydroxy-3-{[4-(morpholin-4-yl)-1,2,5-...)
Affinity DataKd:  0.210nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25768(ICI 118,551 | 1-[(7-methyl-2,3-dihydro-1H-inden-4-...)
Affinity DataKd:  0.550nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25769(Levalbuterol | Salbutamol,(+/-) | albuterol | Prov...)
Affinity DataKd:  759nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25770(Terbutaline,(+/-) | Brethine | 5-[2-(tert-butylami...)
Affinity DataKd:  2.40E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25771(salmeterol xinafoate | 4-(1-hydroxy-2-{[6-(4-pheny...)
Affinity DataKd:  1.47nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213098((R,R)-(-)-fenoterol | US9492405, (R,R)-1 | CHEMBL3...)
Affinity DataKd:  347nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213106((R,S)-(-)-fenoterol | US9492405, (R,S)-1 | CHEMBL2...)
Affinity DataKd:  3.72E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213103((S,R)-(+)-fenoterol | US9492405, (S,R)-1 | CHEMBL2...)
Affinity DataKd:  1.02E+4nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213114((S,S)-(+)-fenoterol | US9492405, (S,S)-1 | CHEMBL3...)
Affinity DataKd:  2.75E+4nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213099((R,R)-(-)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKd:  479nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213120((R,S)-(-)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKd:  1.95E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM206769( (S,R)-2 | US9492405, (S,R)-2)
Affinity DataKd:  5.25E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM206770( (S,S)- 2 | US9492405, (S,S)-2)
Affinity DataKd:  1.58E+4nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213108((R,R)-(-)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKd:  2.95E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213112((R,S)-(-)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKd:  7.94E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213116((S,R)-(+)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKd:  2.29E+4nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213118((S,S)-(+)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKd:  2.88E+4nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM206771((R,R)-4 | US9492405, (R,R)-4)
Affinity DataKd:  1.86E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM206772((R,S)-4 | US9492405, (R,S)-4)
Affinity DataKd:  6.03E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM206773((S,R)- 4 | US9492405, (S,R)-4)
Affinity DataKd:  3.09E+4nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM206774((S,S)- 4 | US9492405, (S,S)-4)
Affinity DataKd:  2.88E+4nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213115((R,R)-(-)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKd:  240nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213110((R,S)-(-)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKd:  339nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213096((S,R)-(+)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKd:  1.78E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213101((S,S)-(+)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKd:  2.51E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM206775((R,R)- 6 | US9492405, (R,R)-6)
Affinity DataKd:  9.33E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM206776((R,S)-6 | US9492405, (R,S)-6)
Affinity DataKd:  3.16E+4nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM206777((S,R)- 6 | US9492405, (S,R)-6)
Affinity DataKd:  1.00E+5nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM206778((S,S)-6 | US9492405, (S,S)-6)
Affinity DataKd:  5.62E+4nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetBeta-2 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50213119((R)-(-)-5-(1-hydroxy-2-phenethylaminoethyl)-1,3-be...)
Affinity DataKd:  1.05E+4nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 469 total ) | Next | Last >>
Jump to: